121 related articles for article (PubMed ID: 35790283)
1. High Expression of
Ozaki A; Motomura H; Tamori S; Onaga C; Nagashima Y; Kotori M; Matsuda C; Matsuda A; Mochizuki N; Sato T; Hara Y; Sato K; Miyagi Y; Nagashima Y; Hanawa T; Harada Y; Xiong Y; Sasaki K; Ohno S; Akimoto K
Anticancer Res; 2022 Jul; 42(7):3299-3312. PubMed ID: 35790283
[TBL] [Abstract][Full Text] [Related]
2. Luminal B Breast Cancer Coexpressing
Ozaki A; Matsuda A; Maemura Y; Tada Y; Kasai T; Nagashima Y; Onaga C; Hara Y; Kitabatake K; Tsukimoto M; Tamori S; Sasaki K; Ohno S; Akimoto K
Anticancer Res; 2024 Jan; 44(1):37-47. PubMed ID: 38160009
[TBL] [Abstract][Full Text] [Related]
3. High Expression of
Xiong Y; Motomura H; Tamori S; Ozaki A; Onaga C; Hara Y; Sato K; Tahata K; Harada Y; Sasaki K; Zheng YW; Ohno S; Akimoto K
Anticancer Res; 2022 Nov; 42(11):5223-5232. PubMed ID: 36288878
[TBL] [Abstract][Full Text] [Related]
4. GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.
Motomura H; Tamori S; Yatani MA; Namiki A; Onaga C; Ozaki A; Takasawa R; Mano Y; Sato T; Hara Y; Sato K; Xiong Y; Harada Y; Hanawa T; Tanuma SI; Sasaki K; Ohno S; Akimoto K
Anticancer Res; 2021 Dec; 41(12):5959-5971. PubMed ID: 34848450
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC).
Ma F; Li H; Li Y; Ding X; Wang H; Fan Y; Lin C; Qian H; Xu B
Medicine (Baltimore); 2017 Apr; 96(14):e6561. PubMed ID: 28383433
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells.
Tsukabe M; Shimazu K; Morimoto K; Naoi Y; Kagara N; Shimoda M; Shimomura A; Maruyama N; Kim SJ; Noguchi S
Oncology; 2013; 85(4):248-56. PubMed ID: 24192633
[TBL] [Abstract][Full Text] [Related]
7. High Expression of
Motomura H; Nozaki Y; Onaga C; Ozaki A; Tamori S; Shiina TA; Kanai S; Ohira C; Hara Y; Harada Y; Takasawa R; Hanawa T; Tanuma SI; Mano Y; Sato T; Sato K; Akimoto K
Anticancer Res; 2020 Jan; 40(1):35-52. PubMed ID: 31892551
[TBL] [Abstract][Full Text] [Related]
8. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness.
Shima H; Kida K; Adachi S; Yamada A; Sugae S; Narui K; Miyagi Y; Nishi M; Ryo A; Murata S; Taniguchi H; Ichikawa Y; Ishikawa T; Endo I
Breast Cancer Res Treat; 2018 Aug; 170(3):507-516. PubMed ID: 29693231
[TBL] [Abstract][Full Text] [Related]
9. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
Kuroda T; Hirohashi Y; Torigoe T; Yasuda K; Takahashi A; Asanuma H; Morita R; Mariya T; Asano T; Mizuuchi M; Saito T; Sato N
PLoS One; 2013; 8(6):e65158. PubMed ID: 23762304
[TBL] [Abstract][Full Text] [Related]
10. Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer.
Alamgeer M; Ganju V; Kumar B; Fox J; Hart S; White M; Harris M; Stuckey J; Prodanovic Z; Schneider-Kolsky ME; Watkins DN
Breast Cancer Res; 2014 Apr; 16(2):R44. PubMed ID: 24762066
[TBL] [Abstract][Full Text] [Related]
11. High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
Nozaki Y; Motomura H; Tamori S; Kimura Y; Onaga C; Kanai S; Ishihara Y; Ozaki A; Hara Y; Harada Y; Mano Y; Sato T; Sato K; Sasaki K; Ishiguro H; Ohno S; Akimoto K
PLoS One; 2020; 15(7):e0235747. PubMed ID: 32658903
[TBL] [Abstract][Full Text] [Related]
12. Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.
Mieog JS; de Kruijf EM; Bastiaannet E; Kuppen PJ; Sajet A; de Craen AJ; Smit VT; van de Velde CJ; Liefers GJ
BMC Cancer; 2012 Jan; 12():42. PubMed ID: 22280212
[TBL] [Abstract][Full Text] [Related]
13. ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer.
Xing P; Dong H; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Zheng X; Wu Y; Jin F; Li J
Cell Physiol Biochem; 2018; 49(3):961-970. PubMed ID: 30184527
[TBL] [Abstract][Full Text] [Related]
14. Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
Bane A; Viloria-Petit A; Pinnaduwage D; Mulligan AM; O'Malley FP; Andrulis IL
Breast Cancer Res Treat; 2013 Jul; 140(1):195-205. PubMed ID: 23813303
[TBL] [Abstract][Full Text] [Related]
15. Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.
Kida K; Ishikawa T; Yamada A; Shimada K; Narui K; Sugae S; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
Breast Cancer Res Treat; 2016 Apr; 156(2):261-9. PubMed ID: 26975188
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
[TBL] [Abstract][Full Text] [Related]
17. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
[TBL] [Abstract][Full Text] [Related]
18. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
[TBL] [Abstract][Full Text] [Related]
19. Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
Croker AK; Rodriguez-Torres M; Xia Y; Pardhan S; Leong HS; Lewis JD; Allan AL
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937653
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
